This recent commentary featured in The Lancet Diabetes Endocrinal 2017 focuses on the need for coordinated efforts and a large international database of patients with diabetes and nephropathy.
It refers to ISN and its Advancing Clinical Trials group and Clinical Trial Networks who could be instrumental in achieving this objective.
Read more HERE.
Calling all early-career researchers! Have you published original research in Kidney International®... read more
Kidney International® Pre-transplant Anti-nephrin Antibodies are Specific Predictors of Recurrent Diffuse Podocytopathy... read more
Participants and Educational Ambassadors Laura Castellanos-Reyes and Christine Sethna at the... read more
Nephrology has published the paper "Structures for Quality Assurance and Measurements... read more
A note from Adeera Levin, Chair, 2024-25 ISN Nominating Committee The 2024... read more
Nina Diana, chair of the South African Renal Congress, signs the... read more
The ISN is excited to welcome 39 newly matched pairs to... read more
Please join us in congratulating and welcoming 12 new ISN Fellows... read more
The ISN supports a range of educational initiatives that bring expert... read more
The ISN has added two new webinars to its Rare Kidney... read more
